What if treating early-stage lung cancer could be as simple as lying still for 10 minutes—no surgery, no anesthesia, no hospital stay? In this episode, host James Hiter talks with Dr. Drew Moghanaki, Chief of Thoracic Oncology at UCLA, about SABR (stereotactic ablative radiation)—a game-changing treatment that delivers highly precise radiation in just 1-5 sessions. Learn why every patient should ask for a radiation oncologist consult, how SABR compares to surgery, and why preserving lung tissue matters for long-term quality of life.

Key topics covered:

• What SABR/SBRT is and how it works
• Why treatment takes 5 sessions or less (sometimes just one!)
• The importance of biomarker testing before any local therapy
• How multidisciplinary teams improve treatment decisions
• What the treatment experience is actually like
• The future of lung cancer local therapies

Whether you're newly diagnosed with early-stage lung cancer or exploring treatment options, this conversation delivers practical information and hope through scientific progress.

Show Notes - https://lcfamerica.org/wp-content/uploads/2025/12/AMA-SABR-for-Lung-Cancer-Show-Notes.pdf Transcript - https://lcfamerica.org/wp-content/uploads/2025/12/AMA-SABR-for-Lung-Cancer-Transcript.pdf Video - https://youtu.be/a6q2ZaJp9BQ